High prevalence of metallo-β-lactamase-mediated resistance challenging antimicrobial therapy against Pseudomonas aeruginosa in a Brazilian teaching hospital

Epidemiology and Infection

Volumn 135, Issue 2, 2007, Pages 343-345

  Zavascki, A P ^a,b   Goldani, L Z ^b,c   Goncalves A L S ^c   Martins, A F ^c   Barth, A L ^b,c  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BRAZIL; CLONAL VARIATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA RESTRICTION; ENZYME SYNTHESIS; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; PSEUDOMONAS AERUGINOSA; TEACHING HOSPITAL;

BETA-LACTAMASES; BRAZIL; CHI-SQUARE DISTRIBUTION; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; HOSPITALS, TEACHING; HUMANS; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 33847392634     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268806006893     Document Type: Article

References (12)

1. Livermore DM. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: Our worst nightmare? Clinical Infectious Diseases 2002; 34: 634-640.
2. Jacoby GA, Munoz-Price LS. The new beta-lactamases. New England Journal of Medicine 2005; 352: 380-391.
3. Walsh TR, et al. Metallo-beta-lactamases: The quiet before the storm? Clinical Microbiology Reviews 2005; 18: 306-325.
4. Andrade SS, et al. Increasing prevalence of antimicrobial resistance among Pseudomonas aeruginosa isolates in Latin American medical centers: 5 year report of the SENTRY Antimicrobial Surveillance Program (1997-2001). Journal of Antimicrobial Chemotherapy 2003; 52: 140-141.
5. Gales AC, et al. Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo-β-lactamase. Journal of Antimicrobial Chemotherapy 2003; 52: 699-702.
6. Sader HS, et al. IMPs, VIMs and SPMs: The diversity of metallo-beta-lactamases produced by carbapenem-resistant Pseudomonas aeruginosa in a Brazilian hospital. Clinical Microbiology and Infection 2005; 1: 73-76.
7. Zavascki AP, et al. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-β-lactamase in a teaching hospital in southern Brazil. Journal of Antimicrobial Chemotherapy 2005; 56: 1148-1151.
8. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial disk Susceptibility Tests. NCCLS Document M100-S10. Wayne, PA: NCCLS, 2004.
9. Gales AC, Reis AO, Jones RN. Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: Review of available interpretative criteria and quality control guidelines. Journal of Clinical Microbiology 2001; 39: 183-190.
10. Arakawa Y, et al. Convenient test for screening metallo-beta-lactamase-producing gram-negative bacteria by using thiol compounds. Journal of Clinical Microbiology 2000; 38: 40-43.
11. Kaufmann ME. Pulsed-field gel electrophoresis. Methods in Molecular Medicine 1998; 15: 17-31.
12. Tenover FC, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial strain typing. Journal of Clinical Microbiology 1995; 33: 2233-2239.